|
Volumn 362, Issue 24, 2010, Pages 2241-2243
|
Enrolling pregnant women in research - Lessons from the H1N1 influenza pandemic
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMOXICILLIN;
ANTIVIRUS AGENT;
OSELTAMIVIR;
ANTHRAX;
DRUG EFFICACY;
DRUG SAFETY;
HUMAN;
INFLUENZA;
INFLUENZA VIRUS A H1N1;
MEDICAL RESEARCH;
PANDEMIC INFLUENZA;
PATIENT SAFETY;
PREGNANCY OUTCOME;
PREGNANT WOMAN;
PRESCRIPTION;
PRIORITY JOURNAL;
SHORT SURVEY;
TREATMENT OUTCOME;
ARTICLE;
CLINICAL TRIAL;
EPIDEMIC;
FEMALE;
PATIENT SELECTION;
PREGNANCY;
PREGNANCY COMPLICATION;
CLINICAL TRIALS AS TOPIC;
DISEASE OUTBREAKS;
FEMALE;
HUMANS;
INFLUENZA A VIRUS, H1N1 SUBTYPE;
INFLUENZA, HUMAN;
PATIENT SELECTION;
PREGNANCY;
PREGNANCY COMPLICATIONS, INFECTIOUS;
|
EID: 77953720577
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1003462 Document Type: Short Survey |
Times cited : (71)
|
References (5)
|